CHESTPulmonary Vascular Disease

Pulmonary Vascular Disease

In brief: what’s new and notable in pulmonary vascular disease

Explore new and notable updates in pulmonary vascular disease, including research into best practices for evaluating for pulmonary embolism (PE) in pregnant patients, off-label dosing of direct oral anticoagulants in cardiopulmonary disease, and management of post-COVID-19 pulmonary disease. Read the latest from Networks members in the CHEST Physician® publication, access comprehensive resources to help patients understand their pulmonary arterial hypertension (PAH) diagnosis, and more.

Must-reads and more in CHEST® journal


rivaroxaban versus dalteparin infographic
VISUAL ABSTRACT

This visual abstract compares the efficacy and safety of rivaroxaban versus dalteparin for the treatment of cancer-associated thromboembolism by measuring the cumulative incidence of recurrent venous thromboembolism and worsening of obstruction after 3 months.

VIEW THE DOWNLOADABLE JPEG


CHEST Journal | Access even more pulmonary vascular disease research. READ THE JOURNAL »

Pulmonary vascular disease resources for patients and clinicians

Clinician education resources to explore

Management of Acute Pulmonary Embolism: Pro/Con Debates
E-LEARNING

Management of Acute Pulmonary Embolism: Pro/Con Debates

Some aspects of treatment for acute pulmonary embolism remain controversial. Review pros and cons of each in this course.

Nurse in ICU
GUIDELINES

Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report

Review the latest update to CHEST’s guidelines for antithrombotic therapy and the prevention of thrombosis.

COPD Unmet Needs – The Patient Perspective
PLAYER HUB

VTE Guidelines Detective

Practice your sleuthing skills by reviewing “evidence” for each patient to deduce the appropriate diagnosis and treatment strategy.


Patient education resources to share

A new diagnosis of PAH can be confusing and frightening for patients. Help them better understand their disease and what to expect from treatment with resources covering the symptoms, therapies, and risk factors for PAH and busting common myths surrounding living with this disease. Plus, a comprehensive patient guide offers an in-depth look into every aspect of PAH, from diagnosis to treatment and long-term management.

Advertisement

 

Pulmonary vascular disease news and notes

Follow the latest pulmonary vascular disease news

CHEST JOURNAL PODCAST

Venous Thromboembolism Prophylaxis in Critically Ill Adults

Explore the latest data on preventing venous thromboembolism in critically ill adults, including considerations for generalizing prophylaxis measures across ICU patients.

CHEST PHYSICIAN

Among critically ill adults, low-molecular-weight heparin reduces deep vein thrombosis

Read a summary of findings from a study comparing the efficacy of various treatment strategies for the treatment of thrombosis, including heparin.

E-LEARNING

When Is It Not PAH?

Review how to distinguish between patients with PAH and those with heart or lung disease that presents similarly to PAH.

PULMONARY VASCULAR AND CARDIOVASCULAR NETWORK

Targeted temperature management (TTM) after cardiac arrest: How cool?

Enhance your understanding of targeted temperature management in this review from Section Member-at-Large, Fiore Mastroianni, MD.

CHEST PHYSICIAN

Withholding anticoagulation for isolated subsegmental pulmonary embolism – Houston, we have a problem

Aaron Holley, MD, FCCP, debates recent guidance regarding withholding anticoagulation for some patients with pulmonary embolism.

CHEST PULSE PODCAST

COVID Beyond the ICU: Management of Post-COVID-19 Pulmonary Disease

Review the signs and symptoms of post-COVID-19 pulmonary disease, tools for evaluation, and emerging data on management strategies.

Join the Community

If you’re not already a CHEST member, become one today for access to additional resources, discounts on educational activities, and networking opportunities.

JOIN NOW »